Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01142193
Show Display Options
Rank Status Study
1 Completed
Has Results
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
Condition: Epilepsy
Interventions: Drug: USL255;   Drug: Placebo

Indicates status has not been verified in more than two years